Results of a phase I clinical trial of a T-cell receptor peptide vaccine in patients with multiple sclerosis. I. Analysis of T-cell receptor utilization in CSF cell populations
Authors:
- 1 June 1997
- journal article
- clinical trial
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 76 (1-2) , 15-28
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.Journal of Experimental Medicine, 1994
- Selection for T-cell receptor Vβ–Dβ–Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosisNature, 1993
- Requirement for CD8 + Cells in T Cell Receptor Peptide-Induced Clonal UnresponsivenessScience, 1993
- Analysis of T cell receptor beta chains in Lewis rats with experimental allergic encephalomyelitis: conserved complementarity determining region 3.Journal of Experimental Medicine, 1991
- T Cell Receptor Peptide Therapy Triggers Autoregulation of Experimental EncephalomyelitisScience, 1991
- Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different.Journal of Experimental Medicine, 1989
- In Vivo Activated T Lymphocytes in the Peripheral Blood and Cerebrospinal Fluid of Patients with Multiple SclerosisNew England Journal of Medicine, 1985
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983
- Multiple SclerosisNew England Journal of Medicine, 1982
- The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitisEuropean Journal of Immunology, 1981